All sponsors

InventisBio Co., Ltd

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS9
PHASE 3 / 2-33
RECRUITING7
READOUTS ≤12 MONTHS6
Open InventisBio Co., Ltd on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
D2570-202
NCT07035041
P2Active, not recruitingUC - Ulcerative Colitis; Moderately to Severely Active Ulcerative Colitis1202026-07-30
D-0502
NCT06954961
P3RecruitingBreast Cancer6402026-11-30
D-2570 Tablet
NCT07326813
P3RecruitingPlaque Psoriasis4772027-07-12
D-2570
NCT07130604
P3RecruitingPlaque Psoriasis3902027-07-28
N/Z
NCT07489885
P2RecruitingPsoriasis752027-08
D2570-204
NCT07315061
P2RecruitingPsA (Psoriatic Arthritis)2222027-08-15
D2570-206
NCT07625891
P2RecruitingVitiligo; Non-Segmental Vitiligo (NSV)1602027-11
D-1553
NCT05379946
P1/2Active, not recruitingSolid Tumor922027-12-31 (+42 mo)
D-2570
NCT07311200
P2RecruitingActive Systemic Lupus Erythematosus1202028-08-31